Sfoglia per Autore
Dipotassium Glycyrrhizate Inhibits HMGB1-Dependent Inflammation and Ameliorates Colitis in Mice
2013-01-01 Stronati, L.; Costanzo, M.; Negroni, A.; Palone, F.; Vitali, R.
Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease
2013-01-01 Stronati, L.
Lactobacillus reuteri ATCC55730 in cystic fibrosis
2014-01-01 Stronati, L.
Lactoferrin prevents invasion and inflammatory response following E. coli strain LF82 infection in experimental model of Crohn's disease
2014-01-01 Stronati, L.; Costanzo, M.
Advances in the medical management of paediatric IBD
2014-01-01 Stronati, L.
Role of HMGB1 as a suitable biomarker of subclinical intestinal inflammation and mucosal healing in patients with inflammatory bowel disease
2014-01-01 Stronati, L.; Negroni, A.
Endoplasmic reticulum stress and unfolded protein response are involved in paediatric inflammatory bowel disease
2014-01-01 Stronati, L.; Vitali, R.; Prete, E.; Negroni, A.
Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease
2014-01-01 Stronati, L.; Vitali, R.
Necroptosis is active in children with inflammatory bowel disease and contributes to heighten intestinal inflammation
2014-01-01 Prete, E.; Vitali, R.; Stronati, L.; Negroni, A.
LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease
2015-01-01 Stronati, L.
Apoptosis, necrosis, and necroptosis in the gut and intestinal homeostasis
2015-01-01 Stronati, L.; Negroni, A.
Micronuclei and chromosome aberrations in subjects occupationally exposed to antineoplastic drugs: a multicentric approach
2015-01-01 Stronati, L.; Appolloni, M.; Grollino, M. G.
Dipotassium glycyrrhizate via HMGB1 or AMPK signaling suppresses oxidative stress during intestinal inflammation
2015-01-01 Stronati, L.; Negroni, A.; Pierdomenico, M.; Palone, F.; Vitali, R.
NOD2 Is Regulated by MIR-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease
2016-01-01 Stronati, L.; Costanzo, M.; Prete, E.; Vitali, R.; Cesi, V.
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase
2016-01-01 Stronati, L.
Krill oil reduces intestinal inflammation by improving epithelial integrity and impairing adherent-invasive Escherichia coli pathogenicity
2016-01-01 Stronati, L.; Palone, F.; Negroni, A.; Prete, E.; Cesi, V.; Costanzo, M.
Macrophage Activation in Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) Correlates with Hepatic Progenitor Cell Response via Wnt3a Pathway
2016-01-01 Stronati, L.
Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines
2016-01-01 Stronati, L.
IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes
2018-01-01 Stronati, L.
Functional analysis of gut microbiota and immunoinflammation in children with autism spectrum disorders
2019-01-01 Carissimi, C.; Laudadio, I.; Palone, F.; Fulci, V.; Cesi, V.; Cardona, F.; Alfonsi, C.; Cucchiara, S.; Isoldi, S.; Stronati, L.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile